<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="38a78eca-f770-49a3-8a3a-3f536f3039ec"><labelDrug name="Levatol"><Normalization><mmtx cui="C0306609" preferredWord="Levatol" semType="phsu, orch"/></Normalization></labelDrug><generic name="penbutolol sulfate"/><sentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.1" text="LEVATOL (penbutolol sulfate) tablet" type="negative"><entity charOffset="0:7" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.1.e.0" text="levatol" type="Biomedical_Entity"><Normalization><mmtx cui="C0306609" phraseText="LEVATOL" preferredWord="Levatol" semType="phsu, orch"/><RxNorm RxCui="93113"/></Normalization></entity><entity charOffset="9:27" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.1.e.1" text="penbutolol sulfate" type="Biomedical_Entity"><Normalization><mmtx cui="C0282292" phraseText="(penbutolol sulfate" preferredWord="Penbutolol Sulfate" semType="phsu, orch"/><RxNorm RxCui="7973"/></Normalization></entity><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.1.e.0" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.1.e.1"/></sentence><sentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.2" text="Penbutolol antagonizes the heart rate effects of exercise and infused isoproterenol." type="negative"><entity charOffset="0:10" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.2.e.0" text="penbutolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0030812" phraseText="Penbutolol" preferredWord="Penbutolol" semType="phsu, orch"/><RxNorm RxCui="7973"/></Normalization></entity><entity charOffset="70:83" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.2.e.1" text="isoproterenol" type="Biomedical_Entity"><Normalization><mmtx cui="C0022245" phraseText="infused isoproterenol." preferredWord="Isoproterenol" semType="phsu, orch"/><RxNorm RxCui="82030"/></Normalization></entity><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.2.e.0" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.2.e.1"/></sentence><sentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.7" text="Although  -blockers should be avoided in overt congestive heart failure, levatol  can, if necessary, be used with caution in patients with a history of cardiac failure who are well compensated, on treatment with vasodilators, digitalis and/or diuretics. " type="negative"><entity charOffset="243:252" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.7.e.0" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretics." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="212:224" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.7.e.1" text="vasodilators" type="Biomedical_Entity"><Normalization><mmtx cui="C0042402" phraseText="with vasodilators," preferredWord="Vasodilator Agents" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><entity charOffset="73:80" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.7.e.2" text="levatol" type="Biomedical_Entity"><Normalization><mmtx cui="C0306609" phraseText="levatol" preferredWord="Levatol" semType="phsu, orch"/><RxNorm RxCui="93113"/></Normalization></entity><entity charOffset="226:235" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.7.e.3" text="digitalis" type="Biomedical_Entity"><Normalization><mmtx cui="C0304520" phraseText="digitalis" preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.7.e.1" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.7.e.0"/><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.7.e.2" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.7.e.0"/><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.7.e.3" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.7.e.0"/><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.7.e.2" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.7.e.1"/><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.7.e.1" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.7.e.3"/><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.7.e.2" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.7.e.3"/></sentence><sentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.8" text="Both digitalis and penbutolol slow AV conduction. " type="negative"><entity charOffset="5:14" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.8.e.0" text="digitalis" type="Biomedical_Entity"><Normalization><mmtx cui="C0304520" phraseText="Both digitalis" preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="19:29" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.8.e.1" text="penbutolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0030812" phraseText="penbutolol slow AV conduction." preferredWord="Penbutolol" semType="phsu, orch"/><RxNorm RxCui="7973"/></Normalization></entity><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.8.e.0" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.8.e.1"/></sentence><sentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.9" text="Beta-adrenergic receptor antagonists do not inhibit the inotropic action of digitalis on heart muscle. " type="negative"><entity charOffset="76:85" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.9.e.0" text="digitalis" type="Biomedical_Entity"><Normalization><mmtx cui="C0304520" phraseText="the inotropic action of digitalis" preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="5:36" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.9.e.1" text="adrenergic receptor antagonists" type="Biomedical_Entity"><Normalization><mmtx cui="C0242889" phraseText="Beta-adrenergic receptor antagonists" preferredWord="Adrenergic Antagonists" semType="phsu"/><RxNorm RxCui="1430615"/></Normalization></entity><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.9.e.1" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.9.e.0"/></sentence><sentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.17" text="If angina becomes more pronounced or acute coronary insufficiency develops, administration of levatol  should be reinstated promptly, at least on a temporary basis, and appropriate measures should be taken for the management of unstable angina. " type="negative"><entity charOffset="158:163" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.17.e.0" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="on a temporary basis," preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="94:101" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.17.e.1" text="levatol" type="Biomedical_Entity"><Normalization><mmtx cui="C0306609" phraseText="administration of levatol" preferredWord="Levatol" semType="phsu, orch"/><RxNorm RxCui="93113"/></Normalization></entity><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.17.e.1" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.17.e.0"/></sentence><sentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.21" text="In general, patients with bronchospastic diseases should not receive  -blockers. levatol  should be administered with caution because it may block bronchodilation produced by endogenous catecholamine stimulation of  -2 receptors." type="negative"><entity charOffset="81:88" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.21.e.0" text="levatol" type="Biomedical_Entity"><Normalization><mmtx cui="C0306609" phraseText="blockers. levatol" preferredWord="Levatol" semType="phsu, orch"/><RxNorm RxCui="93113"/></Normalization></entity><entity charOffset="186:199" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.21.e.1" text="catecholamine" type="Biomedical_Entity"><Normalization><mmtx cui="C0007412" phraseText="produced by endogenous catecholamine stimulation of  -2 receptors." preferredWord="Catecholamines" semType="phsu, nsba"/><RxNorm RxCui="2146"/></Normalization></entity><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.21.e.0" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.21.e.1"/></sentence><sentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.26" text="Beta-blockade also reduces the release of insulin in response to hyperglycemia; " type="negative"><entity charOffset="42:49" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.26.e.0" text="insulin" type="Biomedical_Entity"><Normalization><mmtx cui="C1579433" phraseText="the release of insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="5:13" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.26.e.1" text="blockade" type="Biomedical_Entity"><Normalization><mmtx cui="C3540676" phraseText="Beta-blockade also" preferredWord="Blockade" semType="phsu"/><RxNorm RxCui="1423936"/></Normalization></entity><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.26.e.1" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.26.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.27" lineNumber="21" text="therefore, it may be necessary to adjust the dose of hypoglycemic drugs. " type="irregular"><entity charOffset="34:49" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.27.e.0" text="adjust the dose" type="Caution_Interaction"/><entity charOffset="53:71" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.27.e.2" text="hypoglycemic drugs" type="Drug_Class"><Normalization><mmtx cui="C0020616" phraseText="the dose of hypoglycemic drugs." preferredWord="Hypoglycemic Agents" semType="phsu"/><RxNorm RxCui="5604"/></Normalization></entity><drugInteraction id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.27.ddi.1"><interaction trigger="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.27.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.21" text="In general, patients with bronchospastic diseases should not receive  -blockers. levatol  should be administered with caution because it may block bronchodilation produced by endogenous catecholamine stimulation of  -2 receptors."><entity charOffset="81:88" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.21.e.0" text="levatol" type="Drug"><Normalization><mmtx cui="C0306609" phraseText="blockers. levatol" preferredWord="Levatol" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.22" text="Major Surgery: Chronically administered beta-blocking therapy should not be routinely withdrawn prior to major surgery; "/><middleSentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.23" text="however, the impaired ability of the heart to respond to reflex adrenergic stimuli may augment the risks of general anesthesia and surgical procedures."/><middleSentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.24" text="Diabetes Mellitus and Hypoglycemia: Beta-adrenergic receptor blockade may prevent the appearance of signs and symptoms of acute hypoglycemia, such as tachycardia and blood pressure changes. "/><middleSentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.25" text="This is especially important in patients with labile diabetes. "/><middleSentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.26" text="Beta-blockade also reduces the release of insulin in response to hyperglycemia; "/></relation><relation type="hasObject"><entity id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.27.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.37" text="levatol  has been used in combination with hydrochlorothiazide in at least 100 patients without unexpected adverse reactions." type="negative"><entity charOffset="0:7" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.37.e.0" text="levatol" type="Biomedical_Entity"><Normalization><mmtx cui="C0306609" phraseText="levatol" preferredWord="Levatol" semType="phsu, orch"/><RxNorm RxCui="93113"/></Normalization></entity><entity charOffset="43:62" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.37.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="with hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.37.e.0" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.37.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.38" lineNumber="35" text="In one study, the combination of penbutolol and alcohol increased the number of errors in the eye-hand psychomotor function test." type="regular"><entity charOffset="33:43" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.38.e.0" text="penbutolol" type="Drug"><Normalization><mmtx cui="C0030812" phraseText="the combination of penbutolol" preferredWord="Penbutolol" semType="phsu, orch"/><RxNorm RxCui="7973"/></Normalization></entity><entity charOffset="48:55" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.38.e.1" text="alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="alcohol" preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="80:128" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.38.e.2" text="errors in the eye-hand psychomotor function test" type="Specific_Interaction"/><drugInteraction id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.38.ddi.1"><interaction trigger="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.38.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.38.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.38.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.38.e.0" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.38.e.1" trigger="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.38.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.39" lineNumber="37" text="Penbutolol increases the volume of distribution of lidocaine in normal subjects. " type="regular"><entity charOffset="0:10" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.39.e.0" text="Penbutolol" type="Drug"><Normalization><mmtx cui="C0030812" phraseText="Penbutolol" preferredWord="Penbutolol" semType="phsu, orch"/><RxNorm RxCui="7973"/></Normalization></entity><entity charOffset="11:47" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.39.e.1" text="increases the volume of distribution" type="Decrease_Interaction"/><entity charOffset="51:60" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.39.e.3" text="lidocaine" type="Drug"><Normalization><mmtx cui="C0023660" phraseText="the volume of distribution of lidocaine" preferredWord="Lidocaine" semType="phsu, orch"/><RxNorm RxCui="6387"/></Normalization></entity><entity charOffset="11:47" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.39.e.4" text="increases the volume of distribution" type="SPAN"/><drugInteraction id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.39.ddi.1"><interaction trigger="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.39.e.1"><relations><relation type="hasObject"><entity id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.39.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.39.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.39.e.0" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.39.e.3" trigger="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.39.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.40" lineNumber="37" text="This could result in a requirement for higher loading doses of lidocaine." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.39" Text="Penbutolol increases the volume of distribution of lidocaine in normal subjects. "/><anaphoraEntity charOffset="0:4" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.40.e.0" text="This" type="Expression"/><antecedentEntity charOffset="11:47" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.39.e.1" text="increases the volume of distribution" type="Decrease_Interaction"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.39" Text="Penbutolol increases the volume of distribution of lidocaine in normal subjects. "/><anaphoraEntity charOffset="0:4" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.40.e.0" text="This" type="Expression"/><antecedentEntity charOffset="11:47" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.39.e.4" text="increases the volume of distribution" type="SPAN"/></anaphoraRelation><entity charOffset="23:59" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.40.e.2" text="requirement for higher loading doses" type="Decrease_Interaction"/><entity charOffset="63:72" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.40.e.4" text="lidocaine" type="Drug"><Normalization><mmtx cui="C0023660" phraseText="of lidocaine." preferredWord="Lidocaine" semType="phsu, orch"/><RxNorm RxCui="6387"/></Normalization></entity><drugInteraction id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.40.ddi.1"><interaction trigger="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.40.e.2"><relations><relation type="hasObject"><entity id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.40.e.4"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.39" text="Penbutolol increases the volume of distribution of lidocaine in normal subjects. "><entity id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.39.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.41" text="Cimetidine has no effect on the clearance of penbutolol. " type="negative"><entity charOffset="0:10" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.41.e.0" text="cimetidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0008783" phraseText="Cimetidine" preferredWord="Cimetidine" semType="phsu, orch"/><RxNorm RxCui="2541"/></Normalization></entity><entity charOffset="45:55" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.41.e.1" text="penbutolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0030812" phraseText="no effect on the clearance of penbutolol." preferredWord="Penbutolol" semType="phsu, orch"/><RxNorm RxCui="7973"/></Normalization></entity><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.41.e.0" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.41.e.1"/></sentence><sentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.42" text="The major metabolite of penbutolol is a glucuronide, and it has been shown that cimetidine does not inhibit glucuronidation." type="negative"><entity charOffset="24:34" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.42.e.0" text="penbutolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0030812" phraseText="The major metabolite of penbutolol" preferredWord="Penbutolol" semType="phsu, orch"/><RxNorm RxCui="7973"/></Normalization></entity><entity charOffset="80:90" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.42.e.1" text="cimetidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0008783" phraseText="that cimetidine" preferredWord="Cimetidine" semType="phsu, orch"/><RxNorm RxCui="2541"/></Normalization></entity><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.42.e.0" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.42.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43" lineNumber="41" text="Synergistic hypotensive effects, bradycardia, and arrhythmias have been reported in some patients receiving beta-adrenergic blocking agents when an oral calcium antagonist was added to the treatment regimen." type="regular"><entity charOffset="0:31" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.e.0" text="Synergistic hypotensive effects" type="Specific_Interaction"/><entity charOffset="33:44" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.e.2" text="bradycardia" type="Specific_Interaction"/><entity charOffset="50:61" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.e.4" text="arrhythmias" type="Specific_Interaction"/><entity charOffset="108:139" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.e.6" text="beta-adrenergic blocking agents" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-adrenergic blocking agents" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><entity charOffset="148:171" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.e.7" text="oral calcium antagonist" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="an oral calcium antagonist" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.ddi.1"><interaction trigger="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.e.7"/></relation><relation type="hasObject"><entity id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.e.6"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.ddi.2"><interaction trigger="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.e.7"/></relation><relation type="hasObject"><entity id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.e.6"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.ddi.3"><interaction trigger="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.e.7"/></relation><relation type="hasObject"><entity id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.e.6" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.e.7" trigger="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.43.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.44" lineNumber="43" text="Generally, levatol  should not be used in patients receiving catecholamine-depleting drugs." type="regular"><entity charOffset="11:18" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.44.e.0" text="levatol" type="Drug"><Normalization><mmtx cui="C0306609" phraseText="levatol" preferredWord="Levatol" semType="phsu, orch"/><RxNorm RxCui="93113"/></Normalization></entity><entity charOffset="27:38" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.44.e.1" text="not be used" type="Caution_Interaction"/><entity charOffset="61:90" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.44.e.3" text="catecholamine-depleting drugs" type="Drug_Class"><Normalization><mmtx cui="C0007412" phraseText="catecholamine-depleting drugs." preferredWord="Catecholamines" semType="phsu, nsba"/><mmtx cui="C0013227" phraseText="catecholamine-depleting drugs." preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C3536742" phraseText="catecholamine-depleting drugs." preferredWord="Catecholamine [EPC]" semType="phsu"/><mmtx cui="C0013227" phraseText="catecholamine-depleting drugs." preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="990350"/></Normalization></entity><drugInteraction id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.44.ddi.1"><interaction trigger="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.44.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.44.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.44.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.44.e.0" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.44.e.3" trigger="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.44.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.46" text="Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. " type="negative"><entity charOffset="30:43" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.46.e.0" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers slow atrioventricular conduction" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="5:25" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.46.e.1" text="digitalis glycosides" type="Biomedical_Entity"><Normalization><mmtx cui="C0012253" phraseText="Both digitalis glycosides" preferredWord="Digitalis Glycosides" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.46.e.1" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.46.e.0"/></sentence><sentence biomedicalEntities="0" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.47" lineNumber="47" text="Concomitant use can increase the risk of bradycardia." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.46" Text="Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. "/><anaphoraEntity charOffset="0:15" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.47.e.2" text="Concomitant use" type="Expression"/><antecedentEntity charOffset="5:43" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.46.e.2" text="digitalis glycosides and beta-blockers" type="SPAN"/></anaphoraRelation><entity charOffset="41:52" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.47.e.0" text="bradycardia" type="Specific_Interaction"/><drugInteraction id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.47.ddi.1"><interaction trigger="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.47.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.46" text="Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. "><entity charOffset="5:25" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.46.e.0" text="digitalis glycosides" type="Drug_Class"><Normalization><mmtx cui="C0012253" phraseText="Both digitalis glycosides" preferredWord="Digitalis Glycosides" semType="phsu, carb"/></Normalization></entity></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.46" text="Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. "><entity charOffset="30:43" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.46.e.1" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers slow atrioventricular conduction" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="5" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49" lineNumber="51" text="Care should be taken when using anesthetic agents that depress the myocardium, such as ether, cyclopropane, and trichloroethylene, and it is prudent to use the lowest possible dose of levatol . levatol , like other  -blockers, is a competitive inhibitor of  -receptor agonists, and its effect on the heart can be reversed by cautious administration of such agents (eg, dobutamine or isoproterenol   see OVERDOSAGE). " type="regular"><entity charOffset="0:20" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49.e.0" text="Care should be taken" type="Caution_Interaction"/><entity charOffset="32:77" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49.e.2" text="anesthetic agents that depress the myocardium" type="Drug_Class"><Normalization><mmtx cui="C0002932" phraseText="anesthetic agents" preferredWord="Anesthetics" semType="phsu"/><RxNorm RxCui="817"/></Normalization></entity><entity charOffset="87:92" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49.e.3" text="ether" type="Drug"><Normalization><mmtx cui="C0014994" phraseText="such as ether," preferredWord="ethyl ether" semType="phsu, orch"/><mmtx cui="C0014996" phraseText="such as ether," preferredWord="Ethers" semType="phsu, orch"/><mmtx cui="C1161324" phraseText="such as ether," preferredWord="Etherum, ether, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="1363043"/></Normalization></entity><entity charOffset="94:106" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49.e.4" text="cyclopropane" type="Drug"><Normalization><mmtx cui="C0010587" phraseText="cyclopropane," preferredWord="cyclopropane" semType="phsu, orch"/><RxNorm RxCui="3004"/></Normalization></entity><entity charOffset="112:129" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49.e.5" text="trichloroethylene" type="Drug"><Normalization><mmtx cui="C0040905" phraseText="trichloroethylene," preferredWord="Trichloroethylene" semType="phsu, orch"/><RxNorm RxCui="10777"/></Normalization></entity><entity charOffset="184:191" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49.e.6" text="levatol" type="Drug"><Normalization><mmtx cui="C0306609" phraseText="the lowest possible dose of levatol . levatol ," preferredWord="Levatol" semType="phsu, orch"/><RxNorm RxCui="93113"/></Normalization></entity><drugClassMembership drug="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49.e.3" drugClass="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49.e.2"/><drugClassMembership drug="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49.e.4" drugClass="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49.e.2"/><drugClassMembership drug="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49.e.5" drugClass="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49.e.2"/><drugInteraction id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49.ddi.1"><interaction trigger="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49.e.2" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49.e.6" trigger="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.49.e.0" type="Caution_Interaction"/></sentence><sentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.52" text="While taking beta-blockers, patients with a history of severe anaphylactic reaction to a variety of allergens may be more reactive to repeated challenge, either accidental, diagnostic, or therapeutic. " type="negative"><entity charOffset="100:109" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.52.e.0" text="allergens" type="Biomedical_Entity"><Normalization><mmtx cui="C3274161" phraseText="of allergens" preferredWord="Allergen (brand of diphenylpyraline)" semType="phsu, orch"/><RxNorm RxCui="1297244"/></Normalization></entity><entity charOffset="13:26" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.52.e.1" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="taking beta-blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.52.e.1" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.52.e.0"/></sentence><sentence id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.55" text="The usual starting and maintenance dose of levatol , used alone or in combination with other antihypertensive agents, such as thiazide-type diuretics, is 20 mg given once daily." type="negative"><entity charOffset="93:116" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.55.e.0" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="with other antihypertensive agents," preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="43:50" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.55.e.1" text="levatol" type="Biomedical_Entity"><Normalization><mmtx cui="C0306609" phraseText="maintenance dose of levatol ," preferredWord="Levatol" semType="phsu, orch"/><RxNorm RxCui="93113"/></Normalization></entity><entity charOffset="126:149" id="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.55.e.2" text="thiazide diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012802" phraseText="such as thiazide-type diuretics," preferredWord="Thiazide Diuretics" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.55.e.1" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.55.e.0"/><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.55.e.0" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.55.e.2"/><pair ddi="false" e1="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.55.e.1" e2="Dailymed.38a78eca-f770-49a3-8a3a-3f536f3039ec.s.55.e.2"/></sentence><positiveExamples number="5"/><negativeExamples number="21"/></document>